IN THIS ISSUE
Legislation & Regulation
John Carroll
The $50 million needed for regional collaborations was not part of the federal government's budget. Not the end of the world, but not good either.
Tomorrow's Medicine
Thomas Morrow, MD
Natalizumab has received FDA approval. But as with all approved treatments, questions remain about efficacy and clinical importance compared to existing therapies.
News and Commentary